← FDA DRUG APPROVALS

FDA NDA · NDA016675

DECADRON-LA

Sponsor: MERCK

APPLICATION
NDA016675
TYPE
NDA
ORIGINAL APPROVAL
1973-09-06
LATEST ACTION
1996-03-01
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

DECADRON-LA · ReferenceDiscontinued
DEXAMETHASONE ACETATE EQ 8MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · INJECTABLE · INJECTION

Approval history

1996-03-01Manufacturing (CMC) · Supplement 32 · standardAP
1993-08-27Labeling · Supplement 28 · standardAP
1989-12-11Manufacturing (CMC) · Supplement 27 · standardAP
1989-05-16Labeling · Supplement 19 · standardAP
1985-03-08Labeling · Supplement 20 · standardAP
1983-02-21Manufacturing (CMC) · Supplement 18 · standardAP
1982-03-04Manufacturing (CMC) · Supplement 16 · standardAP
1981-12-21Manufacturing (CMC) · Supplement 15 · standardAP
1981-12-03Manufacturing (CMC) · Supplement 13 · standardAP
1979-08-08Labeling · Supplement 12 · standardAP
1973-09-06Type 2 - New Active Ingredient · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →